CHELMSFORD, Mass., March 13 /PRNewswire/ -- Magellan Biosciences, a leading provider of advanced detection, automated sample handling, and complete solutions for biomedical research and clinical-diagnostic applications, will highlight products designed to improve outcomes from discovery to diagnostics at PITTCON 2006, held March 12-17 in Orlando, Florida. ESA will launch the Corona(TM) Plus Charged Aerosol Detector (CAD(TM)), which builds on its award-winning Corona CAD to add greater compatibility with solvents used in industrial, chemical, and polymer analyses. Dynex will preview its new DS2(TM), an automated ELISA processing system designed for the needs of demanding lower-throughput labs -- from immunology to infectious disease, drug discovery, food safety, and drugs-of- abuse testing.
"Great things happen when you work directly with potential customers, ask them what they need to do their jobs more effectively, design your new products accordingly, and deliver the utmost in quality and service," said Magellan's President and CEO, Robert J. Rosenthal. "They turn into loyal customers who will buy more of what you have to offer, and turn to you every time they have a new analytical challenge to solve. Simply put, we are successful when we help our discovery and diagnostic customers to be successful. We're pleased that's been our experience with ESA's Corona CAD, last year's winner of the PITTCON Editors' Silver Award. Today, Corona is deployed at every major pharmaceutical and biotech company worldwide. These companies are developing a wide range of Corona-based methods for analytical development, process analytical, and manufacturing QC, and are transferring them in record time to their facilities around the world. Consequently, sales of the Corona continue to accelerate."
"We expect that Dynex's DS2 will likewise fill an important unmet need in the marketplace. There are thousands of labs around the world that have long wanted the benefits that a high-performance automated system brings -- improved reliability, accuracy, security, and ease of use -- but with their throughput needs, they couldn't justify the expense of a large system. We are confident the DS2 will be successful because it is designed to deliver exactly what its customer base has been asking for: it is a two-plate, open system that performs the entire complement of analytical steps required for virtually any ELISA immunoassay. The DS2 features the most advanced and user-friendly controls available, operating as a full walk-away system with sample ID-bar-code reading, chain-of-custody, and instrument-diagnostic capabilities."
Other ESA highlights include its new streamlined, Version 3.0 CoulArray(R) application software -- now fully compliant with FDA 21 CFR Part 11; a new direct interface with Agilent Technologies' ChemStation(R) chromatography software for the company's Corona CAD and Coulochem III HPLC detectors; as well as its recently launched BioStat(TM) multi-mode potentiostat, which is compatible with virtually any electrochemical sensor or electrode. Also on view will be Dynex's TRIAD(TM) multimode fluorescence, luminescence, and absorbance reader, the Spectra MR(TM) scanning microplate spectrophotometer, and the MLX(TM) luminometer.
Founded in 1968, ESA Bioscience, Inc. enables answers to the most-pressing applications challenges by delivering unique and valuable analytical systems, HPLC instruments, advanced detectors, related components and reagents, as well as services to the analytical laboratory and clinical point-of-care setting. ESA is a wholly owned subsidiary of Magellan Bioscience, Inc. For more information, visit http://www.esainc.com.
About Dynex Technologies
The Experts in Microplate Analysis, Dynex Technologies, Inc. is a leading manufacturer of microplate instrumentation incorporating advanced detection and fully automated sample handling, consumables, and accessories used in clinical diagnostics, drug discovery, biomedical research, and industrial applications worldwide. Founded in 1952, and headquartered in Chantilly, Virginia, Dynex is a wholly owned subsidiary of Magellan Biosciences. For more information, visit http://www.dynextechnologies.com.
About Magellan Biosciences
Magellan Biosciences develops point-of-care products, related consumables, and automated laboratory systems for clinical diagnostics and biomedical research worldwide. These tools enable scientists and clinicians to produce better, more-reliable results. And improved results help drive better outcomes: a new understanding of health and disease, earlier, more-accurate diagnoses -- breakthrough discoveries that can lead to novel treatments, new cures -- innovations to enhance life. Magellan serves customers through its wholly owned subsidiaries: ESA Biosciences, Dynex Technologies, and TekCel. For more information, visit http://www.magellanbio.com.
Contact: Caroline A. Grossman